Professur für Translationale Frauenheilkunde und Geburtshilfe

Universitätsstraße 21/23
91054 Erlangen

Publications (Download BibTeX)

Go to first page Go to previous page 1 of 15 Go to next page Go to last page

Mavratzas, A., Baek, S., Gerber, B., Schmidt, M., Moebus, ., Foerster, F.,... Marine, F. (2019). Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study. BREAST , 45, 22-28.
Noske, A., Möbus, V., Weber, K., Schmatloch, S., Weichert, W., Köhne, C.H.,... Denkert, C. (2019). Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node–positive study. European journal of cancer, 114, 76-88.
Turner, N.C., Telli, M.L., Rugo, H.S., Mailliez, A., Ettl, J., Grischke, E.-M.,... Robson, M.E. (2019). A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO). Clinical Cancer Research, 25(9), 2717-2724.
Ferreira, M.A., Gamazon, E.R., Al-Ejeh, F., Aittomaki, K., Andrulis, I.L., Anton-Culver, H.,... Yip, D. (2019). Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nature Communications, 10.
Deniz, M., Degregorio, A., Degregorio, N., Bekes, I., Widschwendter, P., Schochter, F.,... Friedl, T.W.P. (2019). Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study. BREAST , 44, 81-89.
Wunderle, M., Pretscher, J., Brucker, S.Y., Volz, B., Hartmann, A., Fiessler, C.,... Rauh, C. (2019). Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment, 174(2), 453-461.
Escala-Garcia, M., Guo, Q., Doerk, T., Canisius, S., Keeman, R., Dennis, J.,... Schmidt, M.K. (2019). Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer, 120(6), 647-657.
Hartkopf, A.D., Mueller, V., Woeckel, A., Lux, M.P., Janni, W., Nabieva, N.,... Tesch, H. (2019). Update Breast Cancer 2019 Part 1-Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer. Geburtshilfe und Frauenheilkunde, 79(3), 256-267.
Janni, W., Schneeweiss, A., Mueller, V., Woeckel, A., Lux, M.P., Hartkopf, A.D.,... Ettl, J. (2019). Update Breast Cancer 2019 Part 2-Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice. Geburtshilfe und Frauenheilkunde, 79(3), 268-280.
Banys-Paluchowski, M., Witzel, I., Aktas, B., Fasching, P., Hartkopf, A., Janni, W.,... Mueller, V. (2019). The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer. Scientific Reports, 9.
Von Minckwitz, G., Huang, C.-S., Mano, M.S., Loibl, S., Mamounas, E.P., Untch, M.,... Geyer, C.E. (2019). Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer. New England Journal of Medicine, 380(7), 617-628.
Buckley, M.A., Woods, N.T., Tyrer, J.P., Mendoza-Fandino, G., Lawrenson, K., Hazelett, D.J.,... Freedman, M.L. (2019). Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. Cancer Research, 79(3).
Brunner, M., Schneider, I.H.F., Guenther, K., Grützmann, R., & Matzel, K. (2019). Permacol collagen paste for cryptoglandular and Crohn's anal fistula. Techniques in Coloproctology, 23(2), 135-141.
Hadji, P., Stoetzer, O., Decker, T., Kurbacher, C.M., Marme, F., Schneeweiss, A.,... Tesch, H. (2019). The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial. Journal of Bone Oncology, 14.
Arkadius, P., Marie, T., Fabienne, S., Thomas, W.P.F., Brigitte, R., Andreas, H.,... Tanja, F. (2019). Circulating tumor cells in metastatic breast cancer: clinical relevance and biological potential. Current Opinion in Obstetrics & Gynecology, 31(1), 76-81.
Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X.-O., Cai, Q.,... Long, J. (2019). Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Cancer Research, 79(3).
Fasching, P., Schneeweiss, A., Kolberg, H.-C., Ettl, J., Fehm, T.N., Overkamp, F., & Lueftner, D. (2019). Translational highlights in breast cancer research and treatment: recent developments with clinical impact. Current Opinion in Obstetrics & Gynecology, 31(1), 67-75.
Matthies, L.M., Taran, F.-A., Keilmann, L., Schneeweiss, A., Simoes, E., Hartkopf, A.D.,... Wallwiener, M. (2019). An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study. Journal of Medical Internet Research, 21(1), e10004-.
Lux, M.P., Nabieva, N., Hartkopf, A.D., Huober, J., Volz, B., Taran, F.-A.,... Brucker, S.Y. (2019). Therapy landscape in patients with metastatic HER2-positive breast cancer: Data from the PRAEGNANT real-world breast cancer registry. Cancers, 11(1).
Nabieva, N., Häberle, L., Brucker, S.Y., Janni, W., Volz, B., Löhberg, C.,... Fasching, P. (2019). Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients. International Journal of Cancer.

Last updated on 2019-24-04 at 10:28